medline.ch Onkologie Gynäkologische Tumoren

	Patient-reported outcomes in clinical trials leading to breast cancer drug approvals: are we making them count? Breast Cancer Res Treat Margolis S, Guirguis AN, Lee C, Smith S, LeVee A, Lipsyc-Sharf MD, Bardia A, Sedrak MS. PMID: 42573832 [PubMed - indexed for MEDLINE]
	Self-reported racial and ethnic discrimination in patient-provider interactions and the initiation of adjuvant therapies for breast cancer in the pathways study. Breast Cancer Res Treat Bitsie KR, Pearson TA, Kwan ML, Yaghjyan L, Scarton L, Shariff-Marco S, Andraos TY, D'Addario LL, Kushi LH, Cheng TD. PMID: 42573830 [PubMed - indexed for MEDLINE]
	Investigating POLG-driven modulation of cancer stemness: a pilot study in breast cancer cells. Aging (Albany NY) Chinigò C, Sugden CJ, Fiorillo M, Cappello AR, Sotgia F, Lisanti MP. PMID: 42573790 [PubMed - indexed for MEDLINE]
	Interstitial lung disease in metastatic breast cancer: a landscape review using SEER-Medicare. Breast Cancer Res Treat Pinheiro LC, An A, Landry CA, Tonorezos E, Aronson KI. PMID: 42573635 [PubMed - indexed for MEDLINE]
	Pharmacological treatment for uterine fibroids. Cochrane Database Syst Rev Garg A, Brennan L, Brito LGO, Nagels H, Beros A. PMID: 42573029 [PubMed - indexed for MEDLINE]
	Proteomic Biomarker Discovery in Breast Cancer: Advances, Challenges, and Translational Prospects. J Biochem Mol Toxicol Hassani M, Morshedi I, Matmurotov KJ, Tulkinovna IS, Mukhamedovich AM, Khorsandi M, Ugli ARE, Yang T, Lin X. PMID: 42573022 [PubMed - indexed for MEDLINE]
	Clinical assessment and management of bone health in non-metastatic breast cancer patients: a best practice implementation project. JBI Evid Implement Zhao H, Zhou C, Wu Y, Dong J, Guo J, Ma L, Peng Y, Yang H, Li W. PMID: 42572986 [PubMed - as supplied by publisher]
	Efficacy of Acupuncture for Insomnia After Chemotherapy in Breast Cancer: A Randomized Sham-Controlled Trial. Nat Sci Sleep Li J, Liu Z, Li L, Xia M, Chen X, Mei Y, Zhang Y, Chen Y. PMID: 42572762 [PubMed]
	Reproductive and Perinatal Outcomes After Trachelectomy: Vaginal Microbiota and Early Preterm Birth. J Obstet Gynaecol Res Takemura H, Taki M, Okamoto H, Ikeda A, Okunomiya A, Chigusa Y, Mogami H, Horie A, Mandai M. PMID: 42572375 [PubMed - indexed for MEDLINE]
	Pelvic Wandering Spleen Mimicking an Ovarian Germ Cell Tumor. J Obstet Gynaecol Res Mammadova G, Ersak B, K, Çak. PMID: 42572374 [PubMed - indexed for MEDLINE]
	Population Pharmacokinetics and Exposure-Response Analyses of Vepdegestrant, a First-in-Class PROteolysis-TArgeting Chimera Estrogen Receptor Degrader. J Clin Pharmacol Yang DZ, Masters JC, Wang H, Tran L, Zhang Y, Lee KC, Tan W, Jermain B. PMID: 42572241 [PubMed - indexed for MEDLINE]
	Current Advances of Molecular Biomarkers and Liquid Biopsies Techniques in Ovarian Cancer. Cancer Med Zhang J, Shan W, Yu J, Shi H, Xu Q, Shang H. PMID: 42572185 [PubMed - indexed for MEDLINE]
	Randomized phase 2 trial of a PARP inhibitor TSL-1502 in germline BRCA-mutated, HER2-negative locally advanced/metastatic breast cancer. Signal Transduct Target Ther Lan B, Xu F, Sun T, Qiu F, Wang Y, Wang S, Li W, Zhong Y, Wu X, Ouyang Q, Wang K, Mi X, Liu R, Xu B. PMID: 42572030 [PubMed - indexed for MEDLINE]
	Determinants of mammography screening uptake among women attending family health centers in Ankara, TÃ¼rkiye: a cross-sectional study. BMC Health Serv Res Topcu FB, Çetintepe SP, Baysan C, Türk KN, Özkan S. PMID: 42571012 [PubMed - indexed for MEDLINE]
	Retraction Note: Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study. BMC Cancer Yu L, Shi Q, Jin Y, Liu Z, Li J, Sun W. PMID: 42571011 [PubMed - in process]
	Long-term results of preoperative hypofractionated chemoradiotherapy for high-risk HER2-positive and triple-negative breast cancer subtypes. Clin Transl Oncol Ciérvide R, Montero Á, García-Aranda M, Valero J, Álvarez B, Chen X, Alonso R, López M, Hernando O, Sánchez E, Rubio C. PMID: 42570990 [PubMed - as supplied by publisher]
	Cross-Spatial-Scale Radiomics for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter, Interpretable MRI Study. Acad Radiol Wang P, Wang CX, Jie M, Gao X, Sun X, Zhang H, Cao Y, Yin Y, Li F. PMID: 42570910 [PubMed - as supplied by publisher]
	Predicting Breast Cancer with Super-Resolution Ultrasound-Based Radiomics: A Multicenter Retrospective Study. Acad Radiol Xu J, Zheng Y, Jia X, Hua Q, Xia S, Tang B, Xiong S, Zhou X, Hu Q, Hou X, Yao Y, Yang X, Yang L, Lyu J, Li L, Kong Y, Zheng Y, Hua G, Zhang Y, Wu F, Guo W, Tian Y, Dong Y, Shi J, Zhou J. PMID: 42570906 [PubMed - as supplied by publisher]
	The estrogen-integrin Î±vÎ²3 crosstalk in breast cancer: Modulating PD-L1 and immune evasion. Biomed Pharmacother Crawford DR, Yang YN, Liu FC, Lin CM, Yang YSH, Li ZL, Shih YJ, Mo JK, Yao CJ, Lin HY, Wang K. PMID: 42551188 [PubMed - as supplied by publisher]
	Editorial for "Magnetic Resonance Elastography in Breast Cancer: A Prospective Study on Optimal Imaging Frequency Selection and Differentiation of Molecular Subtypes". J Magn Reson Imaging Shi Y. PMID: 42550858 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 333409

Seite 1 von 16671

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung